Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
Intermittent preventive treatment of malaria in children (IPTc) is a promising new approach to the control of malaria in areas of seasonal malaria transmission but it is not known if IPTc adds to the protection provided by an insecticide-treated net (ITN).An individually randomised, double-blind, pl...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-02-01
|
| Series: | PLoS Medicine |
| Online Access: | http://europepmc.org/articles/PMC3032552?pdf=render |
| _version_ | 1811221757793665024 |
|---|---|
| author | Amadou T Konaté Jean Baptiste Yaro Amidou Z Ouédraogo Amidou Diarra Adama Gansané Issiaka Soulama David T Kangoyé Youssouf Kaboré Espérance Ouédraogo Alphonse Ouédraogo Alfred B Tiono Issa N Ouédraogo Daniel Chandramohan Simon Cousens Paul J Milligan Sodiomon B Sirima Brian Greenwood Diadier A Diallo |
| author_facet | Amadou T Konaté Jean Baptiste Yaro Amidou Z Ouédraogo Amidou Diarra Adama Gansané Issiaka Soulama David T Kangoyé Youssouf Kaboré Espérance Ouédraogo Alphonse Ouédraogo Alfred B Tiono Issa N Ouédraogo Daniel Chandramohan Simon Cousens Paul J Milligan Sodiomon B Sirima Brian Greenwood Diadier A Diallo |
| author_sort | Amadou T Konaté |
| collection | DOAJ |
| description | Intermittent preventive treatment of malaria in children (IPTc) is a promising new approach to the control of malaria in areas of seasonal malaria transmission but it is not known if IPTc adds to the protection provided by an insecticide-treated net (ITN).An individually randomised, double-blind, placebo-controlled trial of seasonal IPTc was conducted in Burkina Faso in children aged 3 to 59 months who were provided with a long-lasting insecticide-treated bednet (LLIN). Three rounds of treatment with sulphadoxine pyrimethamine plus amodiaquine or placebos were given at monthly intervals during the malaria transmission season. Passive surveillance for malaria episodes was established, a cross-sectional survey was conducted at the end of the malaria transmission season, and use of ITNs was monitored during the intervention period. Incidence rates of malaria were compared using a Cox regression model and generalized linear models were fitted to examine the effect of IPTc on the prevalence of malaria infection, anaemia, and on anthropometric indicators. 3,052 children were screened and 3,014 were enrolled in the trial; 1,505 in the control arm and 1,509 in the intervention arm. Similar proportions of children in the two treatment arms were reported to sleep under an LLIN during the intervention period (93%). The incidence of malaria, defined as fever or history of fever with parasitaemia ≥ 5,000/µl, was 2.88 (95% confidence interval [CI] 2.70-3.06) per child during the intervention period in the control arm versus 0.87 (95% CI 0.78-0.97) in the intervention arm, a protective efficacy (PE) of 70% (95% CI 66%-74%) (p<0.001). There was a 69% (95% CI 6%-90%) reduction in incidence of severe malaria (p = 0.04) and a 46% (95% CI 7%-69%) (p = 0.03) reduction in the incidence of all-cause hospital admissions. IPTc reduced the prevalence of malaria infection at the end of the malaria transmission season by 73% (95% CI 68%-77%) (p<0.001) and that of moderately severe anaemia by 56% (95% CI 36%-70%) (p<0.001). IPTc reduced the risks of wasting (risk ratio [RR] = 0.79; 95% CI 0.65-1.00) (p = 0.05) and of being underweight (RR = 0.84; 95% CI 0.72-0.99) (p = 0.03). Children who received IPTc were 2.8 (95% CI 2.3-3.5) (p<0.001) times more likely to vomit than children who received placebo but no drug-related serious adverse event was recorded.IPT of malaria provides substantial protection against malaria in children who sleep under an ITN. There is now strong evidence to support the integration of IPTc into malaria control strategies in areas of seasonal malaria transmission.ClinicalTrials.govNCT00738946. Please see later in the article for the Editors' Summary. |
| first_indexed | 2024-04-12T08:04:40Z |
| format | Article |
| id | doaj.art-a1b5db8e734e401d8109e33ee809bd27 |
| institution | Directory Open Access Journal |
| issn | 1549-1277 1549-1676 |
| language | English |
| last_indexed | 2024-04-12T08:04:40Z |
| publishDate | 2011-02-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj.art-a1b5db8e734e401d8109e33ee809bd272022-12-22T03:41:12ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762011-02-0182e100040810.1371/journal.pmed.1000408Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.Amadou T KonatéJean Baptiste YaroAmidou Z OuédraogoAmidou DiarraAdama GansanéIssiaka SoulamaDavid T KangoyéYoussouf KaboréEspérance OuédraogoAlphonse OuédraogoAlfred B TionoIssa N OuédraogoDaniel ChandramohanSimon CousensPaul J MilliganSodiomon B SirimaBrian GreenwoodDiadier A DialloIntermittent preventive treatment of malaria in children (IPTc) is a promising new approach to the control of malaria in areas of seasonal malaria transmission but it is not known if IPTc adds to the protection provided by an insecticide-treated net (ITN).An individually randomised, double-blind, placebo-controlled trial of seasonal IPTc was conducted in Burkina Faso in children aged 3 to 59 months who were provided with a long-lasting insecticide-treated bednet (LLIN). Three rounds of treatment with sulphadoxine pyrimethamine plus amodiaquine or placebos were given at monthly intervals during the malaria transmission season. Passive surveillance for malaria episodes was established, a cross-sectional survey was conducted at the end of the malaria transmission season, and use of ITNs was monitored during the intervention period. Incidence rates of malaria were compared using a Cox regression model and generalized linear models were fitted to examine the effect of IPTc on the prevalence of malaria infection, anaemia, and on anthropometric indicators. 3,052 children were screened and 3,014 were enrolled in the trial; 1,505 in the control arm and 1,509 in the intervention arm. Similar proportions of children in the two treatment arms were reported to sleep under an LLIN during the intervention period (93%). The incidence of malaria, defined as fever or history of fever with parasitaemia ≥ 5,000/µl, was 2.88 (95% confidence interval [CI] 2.70-3.06) per child during the intervention period in the control arm versus 0.87 (95% CI 0.78-0.97) in the intervention arm, a protective efficacy (PE) of 70% (95% CI 66%-74%) (p<0.001). There was a 69% (95% CI 6%-90%) reduction in incidence of severe malaria (p = 0.04) and a 46% (95% CI 7%-69%) (p = 0.03) reduction in the incidence of all-cause hospital admissions. IPTc reduced the prevalence of malaria infection at the end of the malaria transmission season by 73% (95% CI 68%-77%) (p<0.001) and that of moderately severe anaemia by 56% (95% CI 36%-70%) (p<0.001). IPTc reduced the risks of wasting (risk ratio [RR] = 0.79; 95% CI 0.65-1.00) (p = 0.05) and of being underweight (RR = 0.84; 95% CI 0.72-0.99) (p = 0.03). Children who received IPTc were 2.8 (95% CI 2.3-3.5) (p<0.001) times more likely to vomit than children who received placebo but no drug-related serious adverse event was recorded.IPT of malaria provides substantial protection against malaria in children who sleep under an ITN. There is now strong evidence to support the integration of IPTc into malaria control strategies in areas of seasonal malaria transmission.ClinicalTrials.govNCT00738946. Please see later in the article for the Editors' Summary.http://europepmc.org/articles/PMC3032552?pdf=render |
| spellingShingle | Amadou T Konaté Jean Baptiste Yaro Amidou Z Ouédraogo Amidou Diarra Adama Gansané Issiaka Soulama David T Kangoyé Youssouf Kaboré Espérance Ouédraogo Alphonse Ouédraogo Alfred B Tiono Issa N Ouédraogo Daniel Chandramohan Simon Cousens Paul J Milligan Sodiomon B Sirima Brian Greenwood Diadier A Diallo Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Medicine |
| title | Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. |
| title_full | Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. |
| title_fullStr | Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. |
| title_full_unstemmed | Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. |
| title_short | Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. |
| title_sort | intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide treated bednet in burkina faso a randomised double blind placebo controlled trial |
| url | http://europepmc.org/articles/PMC3032552?pdf=render |
| work_keys_str_mv | AT amadoutkonate intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT jeanbaptisteyaro intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT amidouzouedraogo intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT amidoudiarra intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT adamagansane intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT issiakasoulama intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT davidtkangoye intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT youssoufkabore intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT esperanceouedraogo intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT alphonseouedraogo intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT alfredbtiono intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT issanouedraogo intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT danielchandramohan intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT simoncousens intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT pauljmilligan intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT sodiomonbsirima intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT briangreenwood intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial AT diadieradiallo intermittentpreventivetreatmentofmalariaprovidessubstantialprotectionagainstmalariainchildrenalreadyprotectedbyaninsecticidetreatedbednetinburkinafasoarandomiseddoubleblindplacebocontrolledtrial |